Konrad Mühlethaler

Dr. Konrad Mühlethaler

Institut for Infectious Diseases, University of Berne, Bern, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
HNHa Thu Trang Nguyen
Ha Thu Trang Nguyen
FRFabrizio Romano
Fabrizio Romano
RWRahel Wampfler
Rahel Wampfler
KMKonrad Mühlethaler
Konrad Mühlethaler
ETEgbert Tannich
Egbert Tannich
AOAlexander Oberli
Alexander Oberli
In clinical practice, mixed-species malaria infections are often not detected by light microscopy (LM) or rapid diagnostic test, as a low number of parasites of one species may occur. Here, we report the case of an 8-year-old girl migrating with her family from Afghanistan with a two-species mixed infection with Plasmodium vivax and Plasmodium ovale. This case demonstrates the significance of molecular testing in the detection of mixed-species malaria infections and highlights the importance of a detailed data analysis during the medical validation procedure to prevent underestimation of mixed-species infections. To our knowledge, this is the first case report of a two-species mixed infection comprising both P. vivax and P. ovale confirmed by LM and different real-time polymerase chain reaction (PCR) approaches.

15 April 2022 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
APAngela Peruzzu
Angela Peruzzu
SMScilla Mastrandrea
Scilla Mastrandrea
Alessandro FancelluAlessandro Fancellu
Alessandro Fancellu
PBPiero Bonelli
Piero Bonelli
KMKonrad Mühlethaler
Konrad Mühlethaler
CSCinzia Santucciu
Cinzia Santucciu

1 February 2005 in Infection
Verified
Journal Article
Closed access
PDF file
KMKonrad Mühlethaler
Konrad Mühlethaler
ESE. Scheurer
E. Scheurer
UZU. Zollinger
U. Zollinger
RMR. Markwalder
R. Markwalder
XNX. M. Nguyen
X. M. Nguyen

25 March 2016 in Tropical Diseases, Travel Medicine and Vaccines
Verified
Journal Article
Open access
PDF file
PZPetra Zimmermann
Petra Zimmermann
KMKonrad Mühlethaler
Konrad Mühlethaler
HFHansjakob Furrer
Hansjakob Furrer
CSCornelia Staehelin
Cornelia Staehelin
International travel continues to increase in frequency. Health care providers need a wide understanding of the spectrum of travel related diseases and their management. This retrospective study analyses the demographic and clinical data of 360 travellers returning from the tropics presenting to an outpatient clinic at a tertiary hospital between 2003 - 2007. The aim of this study was to analyse the frequency of presenting symptoms and diseases in ill returning travellers and to correlate them to the areas visited and the duration and purpose of travel. The main symptoms during travel were diarrhoea (n = 200, 56 %) and fever (n = 124, 34 %). Travellers not visiting friends and relatives but with close contact to the local population were at more than two-fold increased risk of diarrhoea (Odds Ratio [OR] 2.5; 95 % confidence interval [CI] 1.1-6.0, p = 0.03) and fever (OR 2.4; 95 % CI 1.1-5.3; p = 0.02) compared to tourist travellers. Travellers visiting friends and relatives (VFR) were not at increased risk for diarrhoea (OR 0.6; 95 % CI 0.3-1.3; p = 0.17), or fever (OR 1.5; 95 % CI 0.7-3.4; p = 0.28). Thirty-two percent of all travellers (n = 115) were diagnosed with a specific pathogen. Malaria (6 %), giardiasis (6 %) and amebiasis (4 %) were the most frequently detected pathogens. The odds of malaria as a cause of the presenting illness was lower among travellers reporting pre-travel advice. Specific antimicrobial treatment was required in around one third of the patients.

3 July 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
ESEmanuel Schmid-Siegert
Emanuel Schmid-Siegert
SRSophie Richard
Sophie Richard
ALAmanda Luraschi
Amanda Luraschi
KMKonrad Mühlethaler
Konrad Mühlethaler
MPMarco Pagni
Marco Pagni
PHPhilippe Hauser
Philippe Hauser
Microbial pathogens commonly escape the human immune system by varying surface proteins. We investigated the mechanisms used for that purpose by Pneumocystis jirovecii. This uncultivable fungus is an obligate pulmonary pathogen which causes pneumonia in immuno-compromised individuals, a major life-threatening infection. Long-read PacBio sequencing was used to assemble a core of subtelomeres of a single P. jirovecii strain from a bronchoalveolar lavage fluid specimen of a single patient. A total of 113 genes encoding surface proteins were identified, including 28 pseudogenes. These genes formed a subtelomeric gene superfamily which included five families encoding adhesive GPI-anchored glycoproteins, and one family encoding excreted glycoproteins. Numerical analyses suggested that diversification of the glycoproteins relies on mosaic genes created by ectopic recombination, and occurs only within each family. DNA motifs suggested that all genes are expressed independently, except those of the family encoding the most abundant surface glycoproteins which are subject to mutually exclusive expression. PCR analyses showed that exchange of the expressed gene of the latter family occurs frequently, possibly favoured by the location of the genes proximal to the telomere because this allows concomitant telomere exchange. Our observations suggest that (i) P. jirovecii cell surface is made of a complex mixture of different surface proteins, with a majority of a single isoform of the most abundant glycoprotein, (ii) genetic mosaicism within each family ensures variation of the glycoproteins, and (iii) the strategy of the fungus consists in the continuous production of new subpopulations composed of cells which are antigenically different.